Brief: Sedana Medical Receives FDA Fast Track Designation In US

Sedana Medical AB (publ)

04/01/2023 07:02

Jan 4 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL RECEIVES FDA FAST TRACK DESIGNATION IN THE
UNITED
STATES
    * FDA HAS GRANTED FAST TRACK DESIGNATION (FTD) FOR
EVALUATION OF
ISOFLURANE VIA SEDACONDA ACD-S DEVICE FOR SEDATION OF
MECHANICALLY VENTILATED PATIENTS IN INTENSIVE CARE (ICU) SETTING
    * SEDANA MEDICAL WILL ENGAGE IN DISCUSSIONS WITH FDA ON HOW
DEVELOPMENT PROGRAM CAN BENEFIT FROM FTD
    * AT PRESENT, GUIDANCE REGARDING TIMELINE IS UNCHANGED

Source text for Eikon:  ID:nWkrG2wpN 
Further company coverage:  SEDANA.ST 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))